Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: Elacestrant|DRUG: Alpelisib|DRUG: Everolimus|DRUG: Ribociclib|DRUG: Palbociclib|DRUG: Capivasertib|DRUG: Abemaciclib
Sponsor: Stemline Therapeutics, Inc.